Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|November 9, 2017
Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapyAyed O Ayed, Sameer A Parikh
Critical Reviews in Oncology/Hematology|July 9, 2015
Immunotherapy for multiple myeloma: Current status and future directionsAyed O Ayed, Lung-Ji Chang, Jan S Moreb
American Journal of Clinical Pathology|February 20, 2015
Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumorsAhmad Alkhasawneh, John D Reith, Tania Zuluaga Toro, et al.
Leukemia Research|August 7, 2010
Relationship of serum imatinib trough level and response in CML patients: long term follow-upAbdalla Awidi, Ayed O Ayed, Nazzal Bsoul, et al.
American Journal of Hematology|July 19, 2017
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximabMary-Kate Malecek, Adam M Petrich, Shaina Rozell, et al.
Targeted Oncology|September 20, 2023
Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial DifferencesJacqueline C Barrientos, Ayed O Ayed, Agnes Cha, et al.
Blood Cancer Journal|June 28, 2018
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studiesAyed O Ayed, Annalisa Chiappella, Levi Pederson, et al.
Pageof 1